Search all trials

Find therapies in clinical trials near you – page 2

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 962
countries: 28
conditions: 2 101

3 962 trials recruiting28 European countries2 101 conditions coveredUpdated today

Quick filters

Plasma cell myeloma refractory

Recruiting

InvestigationalNo placebo

Phase 3 Study Comparing JNJ-79635322 with Teclistamab in Patients with Relapsed or Refractory Multiple Myeloma after 1‑3 Prior Treatments

InvestigationalNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Teclistamab

Contact Research Centre

Ovarian cancer recurrent

Recruiting

Registered drugNo placebo

Rinatabart Sesutecan plus Bevacizumab vs standard care as maintenance for recurrent platinum‑sensitive ovarian cancer after second‑line chemotherapy

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Bevacizumab

Contact Research Centre

Endocrine ophthalmopathy

Recruiting

InvestigationalNo placebo

AMG 732 in Patients With Thyroid Eye Disease Who Did Not Respond or Relapsed After Previous Treatment

InvestigationalNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:AMG 732

Contact Research Centre

Coagulation factor X level

Recruiting

InvestigationalNo placebo

VMX-C001 in Patients Taking Factor Xa Inhibitors Who Need Urgent Surgery or an Invasive Procedure With High Bleeding Risk

InvestigationalNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:VMX-C001

Contact Research Centre

Graves' disease

Recruiting

InvestigationalNo placebo

Long-Term Study of Imeroprubart in Adults With Graves' Disease

InvestigationalNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:IMEROPRUBART

Contact Research Centre

Pericarditis

Recruiting

InvestigationalNo placebo

A study to evaluate the safety and effectiveness of KPL-387 in patients with well-controlled recurrent pericarditis

InvestigationalNo placebo

Italy

Participants:18–64 years · 65+ years

Contact Research Centre

Cardiac function disturbance postoperative+1

Recruiting

Registered drug

A study to evaluate the effectiveness of R2R01 in preventing acute kidney injury in patients at high risk following heart surgery.

Registered drug

Italy

Participants:18–64 years · 65+ years
Substances:R2R01

Contact Research Centre

Mantle cell lymphoma

Recruiting

Registered drugNo placebo

A study to evaluate the effectiveness of pirtobrutinib in elderly and frail patients with mantle cell lymphoma who have not yet received treatment.

Registered drugNo placebo

Italy

Participants:65+ years
Substances:Pirtobrutinib

Contact Research Centre

Clostridium difficile infection

Recruiting

Investigational

A study to evaluate the effectiveness of AZD5148 in preventing the recurrence of Clostridioides difficile infection in adults.

Investigational

Italy

Participants:18–64 years · 65+ years
Substances:AZD5148

Contact Research Centre

Endocrine ophthalmopathy

Recruiting

Investigational

Study of K1-70 compared to placebo for patients with active thyroid eye disease from Graves' disease

Investigational

Italy

Participants:18–64 years · 65+ years
Substances:HUMAN IGG1 MONOCLONAL ANTIBODY AGAINST THYROTROPIN RECEPTOR

Contact Research Centre

Colorectal cancer metastatic

Recruiting

Registered drugNo placebo

Comparing irinotecan plus cetuximab with trifluridine and tipiracil plus bevacizumab for patients with metastatic colorectal cancer as third line treatment

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Bevacizumab

Contact Research Centre

Prostate cancer

Recruiting

Registered drug

A study of saruparib with radiotherapy and hormone therapy for men with high-risk prostate cancer who have a BRCA gene mutation

Registered drug

Italy

Participants:18–64 years · 65+ years
Substances:Abiraterone Acetate

Contact Research Centre

Find therapies in clinical trials near you – page 2

133 trials match your criteria

Plasma cell myeloma refractory

Phase 3 Study Comparing JNJ-79635322 with Teclistamab in Patients with Relapsed or Refractory Multiple Myeloma after 1‑3 Prior Treatments

Ovarian cancer recurrent

Rinatabart Sesutecan plus Bevacizumab vs standard care as maintenance for recurrent platinum‑sensitive ovarian cancer after second‑line chemotherapy

Endocrine ophthalmopathy

AMG 732 in Patients With Thyroid Eye Disease Who Did Not Respond or Relapsed After Previous Treatment

Coagulation factor X level

VMX-C001 in Patients Taking Factor Xa Inhibitors Who Need Urgent Surgery or an Invasive Procedure With High Bleeding Risk

Graves' disease

Long-Term Study of Imeroprubart in Adults With Graves' Disease

Pericarditis

A study to evaluate the safety and effectiveness of KPL-387 in patients with well-controlled recurrent pericarditis

Cardiac function disturbance postoperative+1

A study to evaluate the effectiveness of R2R01 in preventing acute kidney injury in patients at high risk following heart surgery.

Mantle cell lymphoma

A study to evaluate the effectiveness of pirtobrutinib in elderly and frail patients with mantle cell lymphoma who have not yet received treatment.

Clostridium difficile infection

A study to evaluate the effectiveness of AZD5148 in preventing the recurrence of Clostridioides difficile infection in adults.

Endocrine ophthalmopathy

Study of K1-70 compared to placebo for patients with active thyroid eye disease from Graves' disease

Colorectal cancer metastatic

Comparing irinotecan plus cetuximab with trifluridine and tipiracil plus bevacizumab for patients with metastatic colorectal cancer as third line treatment

Prostate cancer

A study of saruparib with radiotherapy and hormone therapy for men with high-risk prostate cancer who have a BRCA gene mutation

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.